AMBEV S.A. current report, Q4 FY2025

Business Context and Reporting Period

This Form 6-K filing by Ambev S.A. covers the month of November 2025. The report is submitted pursuant to Rule 13a-16 of the Securities Exchange Act of 1934 and complies with Article 11 of CVM Instruction # 358/2002. The filing specifically details transactions regarding the company's own securities held in treasury.

Key Financial Metrics

The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on treasury share transactions.

Metric Value
Treasury Shares (Initial Balance) 169,205,404
Treasury Shares (Final Balance) 169,171,789
Shares Delivered (Restricted) 33,615
Transaction Price per Share R$ 11.99
Total Transaction Volume R$ 403,043.85

Material Changes

The only material change reported is a reduction in the company's treasury share balance. On October 2, 2025, the company executed a direct transaction involving the delivery of 33,615 restricted common shares. This resulted in a net decrease of 33,615 shares in the treasury position.

Guidance, Outlook, and Risks

The filing text does not provide management commentary, financial guidance, outlook, risk factors, or contingencies. The document is a statutory disclosure of a specific securities transaction and contains no forward-looking statements.

Investor Verification Checklist

  • Verify the impact of the 33,615 restricted share delivery on total outstanding shares.
  • Confirm the classification of the R$ 11.99 price as the fair value for restricted share delivery.
  • Review the company's Form 20-F for comprehensive financial results, as this 6-K contains no P&L or balance sheet data.
  • Check for subsequent filings regarding the vesting or release of the delivered restricted shares.